Deutsche Bank’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,848,707
Closed -$53M 4022
2022
Q4
$53M Sell
1,848,707
-952,828
-34% -$27.5M 0.03% 493
2022
Q3
$81.7M Buy
2,801,535
+2,427,884
+650% +$55.9M 0.05% 348
2022
Q2
$5.16M Buy
373,651
+346,710
+1,287% +$4.88M ﹤0.01% 1269
2022
Q1
$489K Buy
26,941
+25,054
+1,328% +$359K ﹤0.01% 2763
2021
Q4
$27K Sell
1,887
-1,074
-36% -$16.6K ﹤0.01% 4097
2021
Q3
$52K Buy
2,961
+586
+25% +$15.1K ﹤0.01% 4111
2021
Q2
$72K Buy
2,375
+2,116
+817% +$58.2K ﹤0.01% 4235
2021
Q1
$8K Buy
+259
New +$8.02K ﹤0.01% 4450

Other funds holding SGFY

Deutsche Bank's SGFY Position: Q1 2023 in Review

Deutsche Bank sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 1,848,707 shares — an estimated $53M sold.

Deutsche Bank first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $81.7M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Deutsche Bank reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Deutsche Bank sold 1,848,707 Signify Health, Inc. shares in Q1 2023, an estimated $53M.
  • Deutsche Bank first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Deutsche Bank's Signify Health, Inc. position peaked at $81.7M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.